Psychiatr. pro Praxi, 2010; 11(3): 122-124

AD.

MUDr.Jan Kolouch, CSc.1, MUDr.František Koukolík, DrSc.2, MUDr.Barbora Balíková3
1 Psychiatrická ambulance, Praha
2 Patologicko-anatomické oddělení, Fakultní Thomayerova nemocnice, Praha
3 Klinika zobrazovacích metod, FN Motol Praha

A surprising effect of memantine on the progression of Alzheimer‘s disease

A case report illustrates the effect of memantine in a previously professionally successful physician during the course of his disease from

81 to 85 years of age when cared for in a home setting. During six weeks of medication, the patient regained cognitive and executive

functions of almost premorbid level of social adaptability. Treatment with memantine exhibits a negligible risk of adverse side effects.

This raises the question of usefulness of establishing the treatment with memantine as the first-choice drug therapy.

Keywords: memantine, donepezil, tiapride, Alzheimer‘s disease, social stimulation, CT image, histological finding, AD symptomatology

Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolouch J, Koukolík F, Balíková B. AD. Psychiatr. praxi. 2010;11(3):122-124.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hořejší J. Sympozium 1, ,Alzheimerova choroba". Galén, Praha, 1999.
    2. Jirák R, Obenberger J, Preiss M. Alzheimerova choroba. Pfizer/Maxdorf, Praha, 1998.
    3. Pidrman V. Demence. Grada Publishing, Praha, 2007.
    4. Raboch J, et al. Psychiatrie - doporučené postupy II. Infopharm, Praha, 2006.
    5. Topinková E. Jak správně a včas diagnostikovat demenci. UCB, Praha, 1999.
    6. Zachariasová S. Diagnóza Alzheimer, Galén, Praha, 2000.
    7. Zpravodaj VZP ČR č. 1, 2004, str. 13: Zásady terapie blokátory acetylcholinesterázy a memantinem.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.